腎臓用医療機器とサービスの世界市場- 世界の産業規模、シェア、動向、機会、予測、製品別、用途別、地域別、競合別、2020～2030年

腎臓用医療機器とサービスの世界の世界市場規模は2024年に159億米ドルとなり、2030年までの年間平均成長率（CAGR）は5.15％と、予測期間を通じて安定した成長が予測されています。

腎臓用医療機器は、腎臓や泌尿器系に関連する状態を診断、治療、管理するために設計された特殊な器具、機器、ツールです。これらの機器は腎臓学（腎臓の研究）において極めて重要であり、病院、クリニック、在宅医療など様々なヘルスケア環境で利用されています。この市場には、腫瘍、嚢胞、腎結石などの腎臓関連疾患の診断に使用される超音波装置、CTスキャナー、MRI装置などの画像診断装置を含む幅広い技術が含まれています。慢性腎臓病（CKD）や末期腎臓病（ESRD）などの腎臓病有病率の上昇は、市場成長を促進する主な要因です。要因としては、高齢化、糖尿病、高血圧、生活習慣病などが挙げられ、腎臓用医療機器とサービスの世界を必要とする患者層が拡大しています。

主な市場促進要因

慢性腎臓病（CKD）と末期腎臓病（ESRD）の有病率の増加

慢性腎臓病（CKD）および末期腎臓病（ESRD）の罹患率の増加は、世界腎臓用医療機器とサービスの世界市場拡大の主要因です。腎臓病の罹患率が世界的に上昇するにつれ、治療、機器、サービスに対する需要も増加の一途をたどっています。世界で約7億人がCKDに罹患しており、さらに急性腎障害（AKI）や腎不全の負担を考慮すると、その数は約8億5,000万人に上り、世界人口の10％以上が影響を受けています。この数字は、早期発見やスクリーニングプログラムが普及していないため、過少に表現されている可能性が高いです。CKDがESRDに進行すると、主に透析や関連療法といった継続的な医療介入が必要となります。ESRDを発症する患者が増えるにつれて、透析装置、腎臓モニター、ろ過システム、その他の必須腎臓機器の必要性が高まり、市場開発の原動力となっています。さらに、糖尿病、高血圧、肥満などの危険因子の有病率の上昇が、腎疾患の世界の負担をさらに増大させており、効果的な管理戦略の緊急の必要性を浮き彫りにしています。特に糖尿病は腎臓病の主な原因であり、高血圧と糖尿病を合わせると新規腎不全患者の3分の2を占める。

主な市場課題

経済の不確実性

経済不安は、購買決定、ヘルスケア予算、医療機器・サービスへの投資など、市場のさまざまな側面に影響を与える可能性があります。経済が不安定な時期には、病院やクリニックを含むヘルスケア施設が予算の制約に直面し、設備投資が制限される可能性があります。その結果、腎臓用医療機器とサービスの世界への投資が遅れる可能性があります。また、医療機関がより費用対効果の高いソリューションを求めるため、経済的な課題によって医療機器メーカーやサービスプロバイダーに価格圧力がかかり、利益率に影響を及ぼす可能性もあります。さらに、経済の不確実性は研究開発イニシアチブの資金を減少させ、腎医療機器の革新を阻害する可能性があります。市場の変動、特に株価や投資家の信頼感も経済状況の影響を受ける可能性があり、また患者の行動も影響を受ける可能性があります。

主な市場動向

在宅血液透析

在宅血液透析は、ESRD患者が快適な自宅で透析治療を受けることができるため、ますます人気が高まっています。より柔軟性があり、個人のスケジュールに合わせることができるため、多くの患者がこの選択肢を好んでいます。このような患者中心のアプローチにより、在宅血液透析装置とサービスの需要が高まっています。在宅透析を受ける患者は、透析回数や透析時間を増やすことができるため、より良好な臨床結果を得ることができます。さらに、在宅血液透析では、ヘルスケア施設に頻繁に通う必要がないため、患者やその家族の負担が軽減されます。また、ヘルスケア環境でよく見られる感染症にさらされるリスクも減らすことができます。コスト面では、在宅血液透析は施設での治療に伴う費用を削減することで、より手頃な選択肢を提供します。また、遠隔医療や遠隔モニタリング技術により、ヘルスケアプロバイダーは患者の経過を管理し、必要に応じて治療を調整することができ、安全性と有効性の両方が向上します。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 腎臓用医療機器とサービスの世界市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（透析装置、腎除神経装置、ウェアラブル人工腎臓装置、末梢塞栓防止装置）
  • 用途別（腎不全、慢性腎臓病、末期腎臓病、腎結石症、高血圧、糖尿病、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の腎臓用医療機器とサービスの世界市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の腎臓用医療機器とサービスの世界市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の腎臓用医療機器とサービスの世界市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の腎臓用医療機器とサービスの世界市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの腎臓用医療機器とサービスの世界市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の腎臓用医療機器とサービスの世界市場：SWOT分析

第14章 ポーターのファイブフォース分析

第15章 競合情勢

• Abbott Laboratories Inc.
• B Braun Melsungen AG
• Baxter International Inc
• Becton, Dickinson, and Company
• Boston Scientific Corporation
• DaVita Healthcare Partners, Inc
• Fresenius SE & Co. KGaA
• Infomed SA
• Medtronic Inc.
• Nipro Corporation

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Renal Medical Devices and Services Market was valued at USD 15.90 billion in 2024 and is projected to experience steady growth throughout the forecast period, with a compound annual growth rate (CAGR) of 5.15% through 2030. Renal medical devices are specialized instruments, equipment, and tools designed to diagnose, treat, and manage conditions related to the kidneys and the urinary system. These devices are crucial in nephrology (the study of kidneys) and are utilized in various healthcare settings, including hospitals, clinics, and home care. The market encompasses a wide range of technologies, including imaging devices such as ultrasound machines, CT scanners, and MRI machines, which are used to diagnose kidney-related conditions such as tumors, cysts, and kidney stones. The rising prevalence of kidney diseases, such as chronic kidney disease (CKD) and end-stage renal disease (ESRD), is a major factor driving market growth. Contributing factors include aging populations, diabetes, hypertension, and lifestyle-related health issues, which are expanding the patient base requiring renal medical devices and services.

*Key Market Drivers**

*Increasing Prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)**

The growing incidence of CKD and ESRD is a key driver of expansion in the Global Renal Medical Devices and Services Market. As kidney disease rates rise globally, the demand for treatments, devices, and services continues to grow. Approximately 700 million people globally are affected by CKD, and when considering the additional burden of Acute Kidney Injury (AKI) and kidney failure, the number rises to about 850 million, impacting over 10% of the world's population. This figure is likely an underrepresentation due to the lack of widespread early detection and screening programs. The progression of CKD to ESRD demands continuous medical interventions, primarily dialysis and related therapies. As more patients develop ESRD, the need for dialysis machines, kidney monitors, filtration systems, and other essential renal devices increases, driving market growth. Additionally, the rising prevalence of risk factors such as diabetes, hypertension, and obesity further contributes to the global burden of renal disease, highlighting the urgent need for effective management strategies. Diabetes, in particular, is the leading cause of kidney disease, while hypertension and diabetes together account for two-thirds of new kidney failure cases.

*Key Market Challenges**

*Economic Uncertainty**

Economic instability can influence various aspects of the market, including purchasing decisions, healthcare budgets, and investments in medical devices and services. During periods of economic uncertainty, healthcare facilities, including hospitals and clinics, may face budget constraints, leading to limitations on capital expenditures. As a result, investments in renal medical devices and services may be delayed. Economic challenges can also exert pricing pressure on medical device manufacturers and service providers, as healthcare organizations seek more cost-effective solutions, potentially affecting profit margins. Additionally, economic uncertainty can reduce funding for research and development initiatives, impeding innovation in renal medical devices. The market's volatility, especially in terms of stock prices and investor confidence, may also be affected by economic conditions, as could patient behavior, with some opting to delay elective procedures or explore lower-cost alternatives.

*Key Market Trends**

*Home Hemodialysis**

Home hemodialysis is becoming increasingly popular, offering patients with ESRD the ability to undergo dialysis treatments in the comfort of their own homes. Many patients prefer this option as it provides greater flexibility and can be adapted to their personal schedules. This patient-centered approach has spurred demand for home hemodialysis devices and services. Patients undergoing home dialysis can experience better clinical outcomes due to the ability to dialyze more frequently or for longer durations. Furthermore, home hemodialysis eliminates the need for frequent travel to healthcare facilities, reducing the burden on patients and their families. It can also decrease the risk of exposure to infections commonly found in healthcare settings. From a cost perspective, home hemodialysis offers a more affordable alternative by reducing the expenses associated with facility-based care. Manufacturers are developing more user-friendly and compact machines to facilitate home treatments, while telehealth and remote monitoring technologies enable healthcare providers to manage patients' progress and adjust treatments as needed, enhancing both safety and effectiveness.

*Key Market Players**

Abbott Laboratories Inc.

B Braun Melsungen AG

Baxter International Inc.

Becton, Dickinson, and Company

Boston Scientific Corporation

DaVita Healthcare Partners, Inc.

Fresenius SE & Co. KGaA

Infomed SA

Medtronic Inc.

Nipro Corporation

*Market Segmentation**

The Global Renal Medical Devices and Services Market is segmented as follows:

**By Product:**

Dialysis Equipment

Renal Denervation Devices

Wearable Artificial Kidney Device

Distal Embolic Protection Devices

**By Application:**

Kidney Failure

Chronic Kidney Disease (CKD)

End-Stage Kidney Disease (ESRD)

Renal Kidney Stone Disease

Hypertension

Diabetes

Others

**By Region:**

North America (United States, Canada, Mexico)

Asia-Pacific (China, India, South Korea, Australia, Japan)

Europe (Germany, France, United Kingdom, Spain, Italy)

South America (Brazil, Argentina, Colombia)

Middle East & Africa (South Africa, Saudi Arabia, UAE)

*Competitive Landscape**

The competitive landscape of the market includes a detailed analysis of major companies operating in the Global Renal Medical Devices and Services Market.

*Customizations Available**

This report can be customized according to the specific needs of a company. TechSci Research offers customizations such as the inclusion of detailed company profiles of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Renal Medical Devices and Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Dialysis Equipment, Renal Denervation Devices, Wearable Artificial Kidney Device, Distal Embolic Protection Devices)
  • 5.2.2. Application (Kidney Failure, Chronic Kidney Disease, End-Stage Kidney Disease, Renal Kidney Stone Disease, Hypertension, Diabetes, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Renal Medical Devices and Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Renal Medical Devices and Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Renal Medical Devices and Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Renal Medical Devices and Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Renal Medical Devices and Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Renal Medical Devices and Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Renal Medical Devices and Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Renal Medical Devices and Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. France Renal Medical Devices and Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Renal Medical Devices and Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia-Pacific Renal Medical Devices and Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Renal Medical Devices and Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Renal Medical Devices and Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Renal Medical Devices and Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Renal Medical Devices and Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Renal Medical Devices and Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. South America Renal Medical Devices and Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Renal Medical Devices and Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Renal Medical Devices and Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Renal Medical Devices and Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Middle East and Africa Renal Medical Devices and Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Renal Medical Devices and Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Renal Medical Devices and Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Renal Medical Devices and Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Renal Medical Devices and Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Product & Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (If Listed)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. B Braun Melsungen AG
• 15.3. Baxter International Inc
• 15.4. Becton, Dickinson, and Company
• 15.5. Boston Scientific Corporation
• 15.6. DaVita Healthcare Partners, Inc
• 15.7. Fresenius SE & Co. KGaA
• 15.8. Infomed SA
• 15.9. Medtronic Inc.
• 15.10.Nipro Corporation

16. Strategic Recommendations

17. About Us & Disclaimer